Antitrust Immunity Lets Legacy Airlines Monopolize Transatlantic Growth

The most surprising number in the new Mubboo Flight Route Structure Index 2026 is not a record for the busiest route, but a percentage that feels more like a market share than a statistic. On US linked international routes that grew between 2024 and 2025, no new airline appeared on 151 of the 234 routes that expanded. When you measure the actual seats added, the picture becomes even starker. Airlines that were already flying those routes supplied 84% of all the new capacity. This is not a story about new competition entering the market. It is a story about existing players simply getting bigger.

For the traveler, this means that the illusion of choice on major transatlantic routes is thinner than the departure boards suggest. The Mubboo index, built from data from the US Bureau of Transportation Statistics and other regulators, reveals a structural reality that most passengers never see. We are not choosing between five independent options. We are often choosing between two or three commercial entities that have merged their decision making through joint ventures with antitrust immunity. The growth is real, but the independence behind it is not.

This matters now more than ever because the data shows that the gap is widest on the busiest routes, the ones you are most likely to fly. The index does not just count airline names. It looks at who controls the capacity and whether a second meaningful option existed every single month. The results challenge the common assumption that a crowded market is a competitive one. In the transatlantic corridor, the market is crowded, but the competition is quiet.

The JFK Heathrow Illusion

Take the New York JFK to London Heathrow route, the most high profile transatlantic connection in the world. In 2025, it carried virtually all of its 3.9 million seats across five airlines. Counted by name, the route looks like a healthy market with 3.68 evenly matched operators. But that number is a statistical artifact. Four of those five airlines sit inside two joint businesses that hold antitrust immunity from the US Department of Transportation.

American Airlines and British Airways operate under Order 2010-7-8, while Delta and Virgin Atlantic operate under Order 2013-9-14. Together, these two pairs hold 94.88% of the seats on the route. If you treat each pair as the single commercial decision its immunity permits, the capacity reads as just 2.15 independent operators. JetBlue, with a 5.11% share, is the only independent carrier of any size on that route. The choice is there, but the power is concentrated in two hands.

Across the entire US panel, 447 routes carrying 88 million seats in 2025 fall inside a transatlantic joint business holding US antitrust immunity. This is not a niche issue. It is the backbone of the market. When you book a ticket, you think you are choosing an airline. In many cases, you are choosing a pricing strategy that has been coordinated with a competitor for years under the shield of regulatory approval.

The Seasonality Trap

The Mubboo index also measures continuity, and this is where the US market shows its most fragile edge. Of 427 US routes that had a second airline above 5% of seats across 2025, 170 did not have one in every month. That means for nearly half of those routes, there were months where you effectively had only one real option above a certain threshold. The comparable figure for Taiwan is 8 of 77 routes. The difference is stark.

The study attributes this US gap to a network with heavy seasonal leisure flying rather than to anything about competition. It is a structural feature of how American airlines build their networks. They prioritize peak season capacity over year round consistency. For the traveler, this means that the competition you see in the summer may vanish in the shoulder seasons. The route exists, but the independent option does not.

This is a subtle but critical distinction. A route with two airlines in July is not the same as a route with two airlines all year. The Mubboo index forces us to look at the months, not just the annual average. It reveals a market that is competitive in the headlines but vulnerable in the calendar. The choice is there, but it is not always there when you need it.

What This Means for Your Ticket

If you are planning a transatlantic trip in 2026, this data should change how you book. Do not assume that a route with five airline names is a route with five independent choices. Check the joint venture status. Look at the antitrust immunity orders. Understand that the pricing you see is likely the result of a coordinated strategy, not a competitive auction.

The growth in capacity is real, and the new seats are a good thing for travelers. But the source of that growth is not new competition. It is existing players expanding their dominance. The Mubboo index does not condemn this structure. It simply measures it. And the measurement shows a market that is more concentrated, more seasonal, and less independent than the departure boards would have you believe.

The next time you see a crowded flight board, remember the numbers behind it. 84% of the new seats came from airlines already there. 94.88% of the JFK Heathrow seats are held by two joint ventures. The choice is an illusion of abundance. The reality is a tight oligopoly with a seasonal pulse. Fly accordingly.